Denileukin diftitox is under clinical development by Citius Pharmaceuticals and currently in Phase II for Melanoma.

Denileukin diftitox is under clinical development by Citius Pharmaceuticals and currently in Phase II for Solid Tumor.

Vaccines are responsible for the control of many infectious diseases that were once common in the United States, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German ...

The US regulator has cleared Lymphir (denileukin diftitox) for the treatment of relapsed or refractory cutaneous T-cell ... an IL-2 binding domain with diphtheria toxin fragments, designed to ...

Tecentriq Hybreza, a subcutaneous delivery of the drug, was approved for certain types of sarcoma, in addition to lung, skin and liver cancers. The Food and Drug Administration (FDA) approved ...

The Edo State Government said on Monday that two persons died of diphtheria in the state. DAILY POST reports that Stephenson Ojeifo, the Director of Public Health in the Edo State Ministry of ...

The Nigeria Centre for Disease Control and Prevention has recorded about 12,085 suspected cases of diphtheria infections as of September 11, 2024. The NCDC, however, said that out of the suspected ...

Jamo confirmed that three children had died from the outbreak, attributing the incident to non-compliance with diphtheria vaccination during a routine exercise conducted two months ago.

The Director, Public Health, Edo Ministry of Health, Dr Stephenson Ojeifo, has said that the state recorded two deaths from Diphtheria disease between January and August. Ojeifo disclosed this in ...

“Diphtheria is a serious and highly contagious disease but we are confident that with the community’s cooperation and the collective efforts of the medical team, we can effectively control and ...